Neither of these markers has been validated in primary tumours, although in breast cancer [34] and mesothelioma [42] a subgroup of primary tumours was identified that showed a very high level of the combined HOXB1-9 expression and a high HOX oncogenic to tumour suppressor ratio, respectively. This evidence concerns the gene HOXB1 and neoplasm.